| 2.8 |
8.3 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 2.2 |
6.6 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 2.0 |
5.9 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 1.8 |
5.5 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 1.8 |
7.1 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 1.7 |
5.2 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.4 |
5.8 |
GO:2000546 |
positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 1.4 |
4.3 |
GO:0014873 |
response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
| 1.3 |
10.5 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 1.3 |
2.5 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 1.2 |
6.2 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 1.2 |
3.6 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 1.2 |
18.0 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 1.1 |
9.5 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 1.0 |
3.1 |
GO:0072554 |
arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel lumenization(GO:0072554) blood vessel endothelial cell fate specification(GO:0097101) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of heart induction(GO:1901321) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
| 1.0 |
5.1 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.9 |
4.7 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) negative regulation of filopodium assembly(GO:0051490) |
| 0.9 |
5.6 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.9 |
2.8 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.9 |
2.8 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.9 |
3.6 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.9 |
5.4 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.9 |
2.7 |
GO:0010616 |
regulation of cardiac muscle adaptation(GO:0010612) negative regulation of cardiac muscle adaptation(GO:0010616) |
| 0.9 |
3.5 |
GO:1901204 |
positive regulation of guanylate cyclase activity(GO:0031284) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
| 0.8 |
3.3 |
GO:0032278 |
positive regulation of gonadotropin secretion(GO:0032278) |
| 0.8 |
2.3 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.8 |
3.1 |
GO:0060083 |
smooth muscle contraction involved in micturition(GO:0060083) |
| 0.8 |
3.0 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 0.7 |
4.9 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.7 |
2.1 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.7 |
5.5 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.7 |
4.0 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.7 |
3.3 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.7 |
2.0 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.6 |
1.9 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.6 |
4.1 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.6 |
1.7 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.6 |
2.8 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.5 |
6.0 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.5 |
1.6 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.5 |
4.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.5 |
1.6 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.5 |
1.0 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.5 |
2.6 |
GO:0090234 |
cellular response to testosterone stimulus(GO:0071394) regulation of kinetochore assembly(GO:0090234) |
| 0.5 |
1.5 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 0.5 |
2.0 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.5 |
1.0 |
GO:0070885 |
negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.5 |
4.3 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.5 |
0.9 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.4 |
1.3 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.4 |
0.4 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.4 |
2.6 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.4 |
4.3 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.4 |
0.4 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.4 |
10.2 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.4 |
1.6 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.4 |
1.2 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.4 |
2.8 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.4 |
1.2 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.4 |
2.3 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.4 |
1.5 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.4 |
2.6 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.4 |
2.2 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.4 |
2.2 |
GO:1901524 |
regulation of autophagosome maturation(GO:1901096) regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.4 |
2.5 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.4 |
1.1 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.4 |
5.0 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.4 |
1.4 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.4 |
1.1 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
| 0.3 |
2.1 |
GO:1902861 |
copper ion import into cell(GO:1902861) |
| 0.3 |
0.3 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.3 |
1.7 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.3 |
1.0 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.3 |
2.0 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.3 |
1.0 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.3 |
5.0 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.3 |
1.0 |
GO:0032493 |
response to bacterial lipoprotein(GO:0032493) |
| 0.3 |
2.6 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.3 |
1.6 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.3 |
3.5 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.3 |
1.0 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.3 |
1.6 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.3 |
0.9 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.3 |
1.6 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 |
0.9 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.3 |
3.1 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 |
3.7 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.3 |
0.9 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.3 |
0.9 |
GO:0070093 |
negative regulation of glucagon secretion(GO:0070093) |
| 0.3 |
2.6 |
GO:0002536 |
respiratory burst involved in inflammatory response(GO:0002536) |
| 0.3 |
2.6 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.3 |
2.3 |
GO:0031642 |
negative regulation of myelination(GO:0031642) negative regulation of axon regeneration(GO:0048681) |
| 0.3 |
2.9 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.3 |
2.0 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.3 |
0.8 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.3 |
1.1 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.3 |
1.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.3 |
0.8 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.3 |
0.8 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.3 |
1.3 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.3 |
4.9 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 0.3 |
0.8 |
GO:0019405 |
alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.3 |
2.0 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.2 |
0.7 |
GO:0061687 |
detoxification of inorganic compound(GO:0061687) |
| 0.2 |
1.5 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.2 |
2.5 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.2 |
1.0 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
1.7 |
GO:0051004 |
plasma membrane to endosome transport(GO:0048227) regulation of lipoprotein lipase activity(GO:0051004) |
| 0.2 |
1.9 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.2 |
3.7 |
GO:0034390 |
smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
| 0.2 |
1.4 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.2 |
0.7 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.2 |
0.7 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.2 |
4.5 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.2 |
9.4 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.2 |
1.8 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.2 |
2.4 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.2 |
1.1 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.2 |
1.1 |
GO:0060481 |
lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.2 |
0.8 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.2 |
4.2 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.2 |
1.5 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.2 |
3.6 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.2 |
1.2 |
GO:1903753 |
cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) hard palate development(GO:0060022) negative regulation of p38MAPK cascade(GO:1903753) |
| 0.2 |
5.6 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.2 |
0.8 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.2 |
2.0 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 |
1.4 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.2 |
4.3 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.2 |
1.0 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 |
1.1 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.2 |
0.8 |
GO:0046103 |
inosine biosynthetic process(GO:0046103) |
| 0.2 |
2.6 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.2 |
2.6 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 0.2 |
1.5 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.2 |
1.1 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.2 |
1.6 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.2 |
0.5 |
GO:0061198 |
fungiform papilla formation(GO:0061198) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 0.2 |
4.3 |
GO:0030431 |
sleep(GO:0030431) |
| 0.2 |
1.4 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.2 |
0.5 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.2 |
3.4 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.2 |
1.9 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.2 |
1.4 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 |
1.9 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 |
1.5 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.2 |
0.3 |
GO:0003211 |
cardiac ventricle formation(GO:0003211) |
| 0.2 |
0.3 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.2 |
1.1 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.2 |
0.7 |
GO:0044330 |
pyruvate transport(GO:0006848) canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.2 |
0.8 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 |
2.9 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) |
| 0.2 |
1.4 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.2 |
0.6 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.2 |
0.6 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.2 |
0.5 |
GO:0070857 |
negative regulation of receptor biosynthetic process(GO:0010871) regulation of bile acid biosynthetic process(GO:0070857) |
| 0.2 |
0.6 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.2 |
3.1 |
GO:0060749 |
mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.2 |
2.0 |
GO:0051693 |
actin filament capping(GO:0051693) |
| 0.1 |
0.4 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.1 |
0.9 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
0.4 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 0.1 |
2.6 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.1 |
0.3 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
2.3 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 |
0.7 |
GO:0010993 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.1 |
1.4 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 |
0.4 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.1 |
1.7 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
7.4 |
GO:0060997 |
dendritic spine morphogenesis(GO:0060997) |
| 0.1 |
1.4 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) |
| 0.1 |
5.2 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.1 |
0.8 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
0.3 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.1 |
0.3 |
GO:0090400 |
stress-induced premature senescence(GO:0090400) |
| 0.1 |
0.3 |
GO:0060261 |
positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 |
0.3 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.1 |
6.4 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
1.0 |
GO:0016446 |
somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 |
3.9 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
| 0.1 |
1.1 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
2.6 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.1 |
1.1 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
2.2 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
1.6 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.1 |
4.1 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.1 |
1.1 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.1 |
0.5 |
GO:0015677 |
copper ion import(GO:0015677) |
| 0.1 |
1.2 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
0.5 |
GO:0018202 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.1 |
2.2 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.5 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.1 |
1.6 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.1 |
1.2 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.1 |
0.8 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.4 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.1 |
2.1 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.1 |
2.4 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.5 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
0.9 |
GO:2000773 |
negative regulation of cellular senescence(GO:2000773) |
| 0.1 |
0.9 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.1 |
1.4 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
0.7 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.3 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
2.2 |
GO:0097345 |
mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.1 |
0.4 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.1 |
0.5 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
3.5 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
0.5 |
GO:0051881 |
regulation of mitochondrial membrane potential(GO:0051881) |
| 0.1 |
2.1 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 |
0.1 |
GO:0021847 |
ventricular zone neuroblast division(GO:0021847) |
| 0.1 |
1.2 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
1.7 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.1 |
0.2 |
GO:0086045 |
membrane depolarization during AV node cell action potential(GO:0086045) |
| 0.1 |
1.9 |
GO:0048026 |
positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.1 |
0.2 |
GO:0060686 |
regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
| 0.1 |
0.9 |
GO:0032691 |
negative regulation of interleukin-1 beta production(GO:0032691) |
| 0.1 |
0.6 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
7.0 |
GO:0050807 |
regulation of synapse organization(GO:0050807) |
| 0.1 |
0.3 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.1 |
0.2 |
GO:1902548 |
negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.1 |
0.6 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.6 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.1 |
0.7 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.1 |
1.3 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.1 |
2.9 |
GO:0014003 |
oligodendrocyte development(GO:0014003) |
| 0.1 |
1.1 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.1 |
8.3 |
GO:0007050 |
cell cycle arrest(GO:0007050) |
| 0.1 |
0.3 |
GO:0014719 |
skeletal muscle satellite cell activation(GO:0014719) |
| 0.1 |
0.8 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
1.6 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
1.0 |
GO:0001964 |
startle response(GO:0001964) |
| 0.1 |
0.5 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
1.4 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.1 |
0.8 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.1 |
0.8 |
GO:0060088 |
auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 |
0.1 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 |
0.3 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
1.1 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.1 |
0.3 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.3 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.8 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 |
0.2 |
GO:0015793 |
glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
| 0.1 |
0.2 |
GO:2000612 |
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.1 |
0.5 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
0.2 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.1 |
3.9 |
GO:0051101 |
regulation of DNA binding(GO:0051101) |
| 0.1 |
1.4 |
GO:0034067 |
protein localization to Golgi apparatus(GO:0034067) |
| 0.1 |
11.1 |
GO:0043413 |
protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
| 0.1 |
0.4 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.1 |
0.5 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.3 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
| 0.1 |
0.8 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 |
0.1 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.0 |
0.2 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.0 |
1.0 |
GO:0016572 |
histone phosphorylation(GO:0016572) |
| 0.0 |
1.5 |
GO:0051489 |
regulation of filopodium assembly(GO:0051489) |
| 0.0 |
0.1 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.0 |
0.8 |
GO:0030865 |
cortical cytoskeleton organization(GO:0030865) |
| 0.0 |
0.8 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.0 |
1.1 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) |
| 0.0 |
0.5 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.4 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 |
0.7 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.0 |
0.0 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.0 |
1.3 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.4 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 |
0.7 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.7 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.3 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.4 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.0 |
0.7 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.0 |
0.3 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.0 |
0.3 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.2 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.0 |
0.7 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.0 |
0.3 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.0 |
0.2 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.0 |
0.6 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.1 |
GO:0046210 |
growth plate cartilage chondrocyte proliferation(GO:0003419) regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.0 |
0.4 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.0 |
0.9 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.0 |
1.5 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 |
0.7 |
GO:0048013 |
ephrin receptor signaling pathway(GO:0048013) |
| 0.0 |
0.1 |
GO:0060768 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.0 |
0.5 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
1.0 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.0 |
0.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.6 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.0 |
0.6 |
GO:0018107 |
peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
| 0.0 |
0.7 |
GO:0007569 |
cell aging(GO:0007569) |
| 0.0 |
0.6 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
0.7 |
GO:0051017 |
actin filament bundle assembly(GO:0051017) |
| 0.0 |
0.3 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.0 |
0.3 |
GO:0042491 |
auditory receptor cell differentiation(GO:0042491) |
| 0.0 |
1.0 |
GO:0008286 |
insulin receptor signaling pathway(GO:0008286) |
| 0.0 |
1.8 |
GO:0007179 |
transforming growth factor beta receptor signaling pathway(GO:0007179) |
| 0.0 |
0.1 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.0 |
0.4 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.0 |
0.3 |
GO:0051341 |
regulation of oxidoreductase activity(GO:0051341) |
| 0.0 |
0.9 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.0 |
0.2 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
| 0.0 |
0.6 |
GO:0006672 |
ceramide metabolic process(GO:0006672) |
| 0.0 |
0.0 |
GO:1903750 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.0 |
0.2 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.0 |
0.2 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
1.6 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.0 |
1.0 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.8 |
GO:0021549 |
cerebellum development(GO:0021549) |
| 0.0 |
0.0 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 |
0.0 |
GO:0008594 |
photoreceptor cell morphogenesis(GO:0008594) |
| 0.0 |
0.0 |
GO:1903887 |
motile primary cilium assembly(GO:1903887) |
| 0.0 |
0.3 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.0 |
0.8 |
GO:0007286 |
spermatid development(GO:0007286) |